Regis J - Search Results

1

Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.

Zhan Z, Sandor VA, Gamelin E, Regis J, Dickstein B, Wilson W, Fojo AT, Bates SE. Zhan Z, et al. Among authors: regis j. Blood. 1997 May 15;89(10):3795-800. Blood. 1997. PMID: 9160686 Free article.

2

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. Among authors: regis j. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.

3

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Among authors: regis j. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

4

Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.

Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE. Scala S, et al. Among authors: regis j. Clin Cancer Res. 1995 Dec;1(12):1581-7. Clin Cancer Res. 1995. PMID: 9815959

5

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.

Kang YK, Zhan Z, Regis J, Alvarez M, Robey R, Meadows B, Dickstein B, Lee JS, Otsuki T, Stetler-Stevenson M, et al. Kang YK, et al. Among authors: regis j. Blood. 1995 Aug 15;86(4):1515-24. Blood. 1995. PMID: 7632959 Free article. Clinical Trial.

6

Intrinsic drug resistance in primary and metastatic renal cell carcinoma.

Gamelin E, Mertins SD, Regis JT, Mickley L, Abati A, Worrell RA, Linehan WM, Bates SE. Gamelin E, et al. Among authors: regis jt. J Urol. 1999 Jul;162(1):217-24. doi: 10.1097/00005392-199907000-00071. J Urol. 1999. PMID: 10379790

7

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

Robey RW, Honjo Y, van de Laar A, Miyake K, Regis JT, Litman T, Bates SE. Robey RW, et al. Among authors: regis jt. Biochim Biophys Acta. 2001 Jun 6;1512(2):171-82. doi: 10.1016/s0005-2736(01)00308-x. Biochim Biophys Acta. 2001. PMID: 11406094 Free article.

8

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. Among authors: regis j. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

9

Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.

Chen CC, Meadows B, Regis J, Kalafsky G, Fojo T, Carrasquillo JA, Bates SE. Chen CC, et al. Among authors: regis j. Clin Cancer Res. 1997 Apr;3(4):545-52. Clin Cancer Res. 1997. PMID: 9815718

10

Clinical Reversal of Multidrug Resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Among authors: regis j. Oncologist. 1996;1(4):269-275. Oncologist. 1996. PMID: 10388001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters